He also held leadership positions at GE Healthcare, Bioventus, Varian Medical Systems and Medtronic. Mr. Acuff has an extensive history of sales and management roles within healthcare and has worked in well-established firms and start-up companies alike.

Mr. Acuff holds a Bachelors of Business Administration in Management from The University of Memphis, and Executive Development at Kellogg School of Management, Northwestern University.

In addition to managing an active practice, Dr. Temple is a professor of Orthopedics at Nova Southeastern University and Professor Emeritus at the University of Miami. He is an examiner for the American Board of Orthopedic Surgeons and sits on the boards of various medical, collegiate, and local non-profit and for profit entities, including the American Association of Tissue Banks, the Florida Transplantation and Tissue Advisory Board, the Musculoskeletal Tumor Society, Life Alliance, and OsteoLife. Dr. Temple has received numerous professional awards from national and international medical academies and honor societies, as well as military and educational organizations.

Dr. Temple holds a Bachelor’s degree from Harvard University and his Doctor of Medicine Degree from Jefferson Medical College. He then completed his general and orthopedic surgery internships at Walter Reed Army Medical Center and his musculoskeletal oncology fellowship at Harvard University-Massachusetts General Hospital.

In 2002, Mr. Anderson founded Atlanta-based T2MED, Inc., one of the Southeast’s most innovative private companies in the growing spinal device market. In 2008, he merged T2 into Amendia, Inc. as one of its founding partners. With Mr. Anderson as the President of its Sales and Marketing group, Amendia grew to over $85 million in sales before being acquired by private equity for $190 million. In December 2012, Mr. Anderson licensed a unique stem cell lineage from the University of Miami for potential use in general orthopedics. In March of 2013, VIVEX Biologics was spun out from Amendia as a freestanding entity.

In November 2014, Mr. Anderson was instrumental in the acquisition of the University of Miami Tissue Bank, the oldest and one of the most prestigious human tissue facilities in the world. UMTB immediately became VIVEX Biologics, a fully owned subsidiary of VIVEX Biologics, Inc. In July of 2019, Mr. Anderson transitioned from his role as President and CEO to the role of Vice Chairman. He remains a member of the Board of Directors. Through his leadership and innovation, VIVEX Biologics has grown to become a leading tissue and cell therapy company with scientifically based technologies, an unsurpassed patent portfolio, and significant revenue in the spine and orthopedic space.

Throughout his career, Mr. Anderson has partnered with some of the medical industry’s top experts in the areas of general orthopedics, spine surgery, sports medicine, cardiovascular surgery, ophthalmic surgery, and oncology. He is a member of several other professional organizations and advisory boards, including the Advisory Committee for Surgical Technology at Gwinnett Tech in Lawrenceville, Georgia.

Since 2007, Mr. Salzman has been a Managing Director for Compass Partners LLC, a merchant banking and financial advisory firm that specializes in middle market companies and corporate restructuring. From 2007 until 2022, Mr. Salzman served as a Board Member and principal owner of BP Gamma Medical Supply until it was sold to Rotech Healthcare Inc, which is now part of Owens and Minor (NYSE:OMI). In 2016, Mr. Salzman joined the Board of Checkpoint Therapeutics Inc (CKPT), an immune-oncology bio pharmaceutical company. He served as President of Surgery Works LLC, which was formed by Compass Partners to provide financial management services for ambulatory surgery centers, from 2008 until a controlling interest was sold to Amsurg (NASDAQ: AMSG) in 2012. He continues to serve on the Board of the former Surgery Works surgery centers and provides consulting and advisory services to Amsurg. Prior to joining Compass Partners, Mr. Salzman was President and principal owner of Becker-Parkin Dental Supply, which he sold to Henry Schein Inc (NASDAQ:HSIC) after 20 years of successful growth.

Mr. Salzman is a graduate of Brooklyn Law School and a member in good standing of the New York Bar Association.

As a principal investigator, Mr. Taylor flew a biomedical experiment on Space Shuttle Columbia in 1991 and, because of the experiment and the resulting recognition, he went on to become the cofounder/Vice President of Engineering at Endius, Inc., a Boston-based surgical device company. Endius (originally known as Aust & Taylor Medical, Inc.) became an early entrant of endoscopic/minimally invasive spine surgery and has become known as the pioneering company in endoscopic spine surgery. In March 2007, the world’s largest orthopedic company, Zimmer, acquired Endius in a private transaction. Before being acquired, Endius was one of the fastest- growing spinal device and implant companies in the US. After hiring a seasoned CEO, Tim resigned from Endius in 2000 and joined Amendia/Spinal Elements as Chairman of the Board. He then became Chairman of the Board of VIVEX Biologics.

Mr. Taylor continues to support Department of Defense launches from Cape Canaveral as well as advanced biomedical ventures, bridging the gap of aerospace and biomedical technologies. He holds over 40 patents, serves on medical and nonprofit boards, and published the book Launch Fever.

Prior to ExamWorks, Mr. Perlman was Executive Chairman of TurboChef Technologies, Inc. (NASDAQ:OVEN), the world leader in speed cook technology (of which he acquired control in 2003 and sold to Middleby Corporation (NASDAQ:MIDD) in 2008), PracticeWorks, Inc. (NASDAQ:PRWK), the world leader of dental practice management software and digital radiography (which he sold to Eastman Kodak (NYSE:EK) in 2003), and AMICAS (NASDAQ:AMCS), a leading medical practice management software company (which was sold in two transactions to Cerner Corporation (NASDAQ:CERN) and Merge Technologies, Inc. (NASDAQ:MRGS).

Mr. Perlman is also the Chairman of Compass Partners, LLC, a merchant banking firm specializing in middle market companies, which he founded in 1995. He sits on the boards of various private companies in which Compass has invested.

Mr. Perlman is the donor of the Perlman Grand Prize for the Wharton Business Plan Competition and serves on the Executive Advisory Board of the Wharton Undergraduate School and the Wharton Entrepreneurial Advisory Board. He is a Trustee of the James Beard Foundation and a board member of the Sun Valley Center for the Arts and the Boys and Girls Club of Sarasota.

Mr. Perlman is a graduate of the Wharton School of the University of Pennsylvania and received his Master of Business Administration from the Columbia University Graduate School of Business.